Correlation Between INmune Bio and Anebulo Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both INmune Bio and Anebulo Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining INmune Bio and Anebulo Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between INmune Bio and Anebulo Pharmaceuticals, you can compare the effects of market volatilities on INmune Bio and Anebulo Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in INmune Bio with a short position of Anebulo Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of INmune Bio and Anebulo Pharmaceuticals.
Diversification Opportunities for INmune Bio and Anebulo Pharmaceuticals
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between INmune and Anebulo is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding INmune Bio and Anebulo Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Anebulo Pharmaceuticals and INmune Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on INmune Bio are associated (or correlated) with Anebulo Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Anebulo Pharmaceuticals has no effect on the direction of INmune Bio i.e., INmune Bio and Anebulo Pharmaceuticals go up and down completely randomly.
Pair Corralation between INmune Bio and Anebulo Pharmaceuticals
Given the investment horizon of 90 days INmune Bio is expected to generate 0.87 times more return on investment than Anebulo Pharmaceuticals. However, INmune Bio is 1.14 times less risky than Anebulo Pharmaceuticals. It trades about -0.04 of its potential returns per unit of risk. Anebulo Pharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest 539.00 in INmune Bio on August 29, 2024 and sell it today you would lose (51.00) from holding INmune Bio or give up 9.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 97.67% |
| Values | Daily Returns |
INmune Bio vs. Anebulo Pharmaceuticals
Performance |
| Timeline |
| INmune Bio |
| Anebulo Pharmaceuticals |
INmune Bio and Anebulo Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with INmune Bio and Anebulo Pharmaceuticals
The main advantage of trading using opposite INmune Bio and Anebulo Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if INmune Bio position performs unexpectedly, Anebulo Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Anebulo Pharmaceuticals will offset losses from the drop in Anebulo Pharmaceuticals' long position.| INmune Bio vs. Tff Pharmaceuticals | INmune Bio vs. Anebulo Pharmaceuticals | INmune Bio vs. AN2 Therapeutics | INmune Bio vs. Cue Biopharma |
| Anebulo Pharmaceuticals vs. Valneva SE ADR | Anebulo Pharmaceuticals vs. Bright Minds Biosciences | Anebulo Pharmaceuticals vs. HP Inc | Anebulo Pharmaceuticals vs. Intel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |